A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was 'is a minimally invasive approach for resection of benign cardiac masses superior to standard full sternotomy?' A total of 50 papers were found using the reported search, of which, 11 represented the best evidence to answer the clinical question. The authors, country, journal, date of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. All 11 papers were retrospective studies, from which 4 were case-control studies comparing the minimally invasive approach with conventional full sternotomy, and 7 were case series. There were two minimally invasive techniques used, a right mini-thoracotomy and a partial hemi-sternotomy, the former being the most commonly used. The resection of benign cardiac masses is a low-risk procedure, with no mortality or conversions to full sternotomy reported. From the 4 case-control studies, cross-clamp time was similar in both groups, and only one report found a prolonged perfusion time with the minimally invasive approach. The incidence of major postoperative complications, including bleeding requiring reoperation (average from case-control studies: 0-4.5 vs 0-5.8%), renal failure (0 vs 0-10%) and prolonged ventilation (6-13 vs 11-19%), for the two approaches was similar. The incidence of postoperative stroke was better for the minimally invasive approach in one study (0 vs 14%, P = 0.023). The main advantages of this technique are shorter intensive care unit (26-31 vs 46-60 h) and hospital stay (3.6-5.2 vs 6.2-7.4 days), the minimally invasive approach being significantly better in one and three reports, respectively. We conclude that minimally invasive resection of a benign cardiac mass using a right mini-thoracotomy approach can be performed with an operative morbidity and mortality at least similar to the standard full sternotomy approach. The information currently available for the minimally invasive approach for the resection of benign cardiac masses is limited and based only on retrospective studies and, therefore, prospective studies are required to confirm the potential benefits of minimally invasive surgery. Abstract) cardiac mass OR (Title/Abstract) cardiac masses OR (Title/Abstract) cardiac tumor OR (Title/Abstract) cardiac tumors OR (Title/Abstract) myxoma OR (Title/Abstract) papillary fibroelastoma] AND [(Title/Abstract) minimally invasive OR (Title/ Abstract) mini-thoracotomy OR (Title/Abstract) mini-sternotomy OR (Title/Abstract) hemi-sternotomy OR (Title/Abstract) minithoracotomy OR (Title/Abstract) ministernotomy OR (Title/ Abstract) hemisternotomy OR (Title/Abstract) mini thoracotomy OR (Title/Abstract) mini sternotomy OR (Title/Abstract) hemi sternotomy].
INTRODUCTION
A best evidence topic was constructed according to a structured protocol, fully described in the ICVTS [1] .
THREE PART QUESTION
In [patients undergoing resection of a benign cardiac mass] is [a minimally invasive approach] superior to [standard median sternotomy] in terms of [morbidity and mortality]?
CLINICAL SCENARIO
A 60-year old woman with a history of controlled hypertension was admitted for transient right upper extremity weakness. As part of the workup for transient ischaemic attack, a transthoracic echocardiogram performed revealed a large left atrial myxoma, and resection of the tumour is planned. Is a minimally invasive approach for resection of a benign cardiac mass worse, equal or better than standard sternotomy? 
SEARCH OUTCOME
Using the reported search, 50 papers were found. Articles that did not include information specifically on cardiac masses or tumours resection were excluded, as were review articles, letters to the editor and single case reports. Finally, 11 papers were identified as the best evidence to answer the initial question (Table 1) .
RESULTS

Right mini-thoracotomy approach
In 1998, Ko et al. [2] first reported a case series of 3 patients who underwent removal of atrial myxomas through a right minithoracotomy. They reported no complications, conversion to full sternotomy or deaths, and none of the tumours recurred at 10.5 months' follow-up. In another early report in which 5 patients underwent minimally invasive atrial tumour excision via a right mini-thoracotomy (2 patients) or a partial sternotomy (3 patients), Ravikumar et al. [3] reported a complication rate of 20%, given by one postoperative stroke. Vistarini et al. [4] presented 14 patients undergoing a left atrial myxoma removal through a right minithoracotomy, and showed a similar complication rate, with 7 and 14% of the patients having reoperation for bleeding and postoperative stroke, respectively. At 2 years' follow-up, there were no recurrences.
Bossert et al. [5] published a series of 77 patients undergoing a cardiac tumour removal, including 19 patients with atrial myxomas who had a right mini-thoracotomy approach. Aortic cross-clamp and cardiopulmonary bypass times were longer in the group of patients undergoing a minimally invasive approach, and although not statistically significant, 2 patients in the conventional sternotomy group died compared with none in the minimally invasive group.
The first case-control study of patient undergoing excision of atrial myxomas was reported by Russo et al. [6] Outcomes of 16 patients who had a right mini-thoracotomy were compared with those of 18 who had standard full sternotomy. No differences were noted between the two groups in transfusion requirements, intensive care unit (ICU) or hospital lengths of stay or in-hospital mortality. There were no conversion to full sternotomy, and at 2 years none of the patients had tumour recurrence. In 2010, the same group published the long-term data of 74 patients with resection of a cardiac mass (38 right mini-thoracotomy vs 36 conventional sternotomy) [7] . They demonstrated excellent outcomes of the minimally invasive approach, with no difference compared with the standard approach in regard to most of the postoperative complications and in-hospital and 1-year mortality. In fact, the minimally invasive approach was associated with a shorter hospital stay and lower postoperative strokes, which was related to an overall higher risk for stroke in their conventional sternotomy group, due to higher incidence of atrial fibrillation, thrombi and complex atrial reconstruction.
Our group reported the outcomes of 22 patients who underwent excision of a benign cardiac mass through a right minithoracotomy compared with those of 17 patients who had full sternotomy [8] . No difference in postoperative complications, including mortality, was found between groups. However, the minimally invasive approach was associated with a significantly shorter ICU and total hospital lengths of stay.
Panos and Myers [9] reported their results with a videoassisted right mini-thoracotomy approach for 10 patients with cardiac myxomas. They reported a short ICU length of stay, and 
Partial upper hemi-sternotomy approach
For patients undergoing excision of cardiac masses through a partial hemi-sternotomy, there are limited data, with 3 case series being published [3, 11, 12] . The study by Ravikumar et al. [3] , which included both partial hemi-sternotomy and right minithoracotomy, has already been discussed in the previous section.
Hsu et al. [11] reported 4 patients with papillary fibroelastomas who had uncomplicated resection via a partial sternotomy. On the other hand, Nordstrand and Tam [12] reported 2 patients who had a left atrial myxoma removed through a partial upper hemi-sternotomy, and reported a prolonged hospital length of stay secondary to arrhythmias and pulmonary complications.
CLINICAL BOTTOM LINE
For patients undergoing excision of a benign cardiac mass, minimally invasive surgery primarily by means of a right mini-thoracotomy is feasible and is at least as safe as conventional full sternotomy. It has been shown to be associated with shorter ICU and total hospital lengths of stay, with similar postoperative complications, mortality and tumour recurrence. However, due to the limited number of studies and their retrospective design, the results of minimally invasive surgery for the excision of cardiac masses should be confirmed by prospective studies with larger numbers of patients.
